Le Lézard
Classified in: Health
Subject: LAW/LEGAL ISSUES

HEXO Reaches Settlement After Filing Lawsuit for Trademark Infringement


OTTAWA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO", or the "Company") (TSX: HEXO; NYSE: HEXO) is pleased to announce it has reached a settlement after pursuing legal action against a California business using the HEXO name and trademark.

The California-based defendant, Assi Project Management, LLC ("Assi"), was using HEXOCBD to sell CBD products in the United States. HEXO sued Assi and its principals in the U.S. District Court for the Southern District of California for unfair competition and trademark infringement, arising from their unauthorized selling of CBD products and services under the name HEXOCBD, which the Company alleged infringed HEXO's intellectual property rights, including its trademarks and trade name.

"The HEXO brand is sufficiently established, both in Canada and in the U.S., that if another company ? in the same industry, no less ? uses it as a part of its mark, HEXO believes the situation creates confusion for the consumer and potential for reputational issues, and is ultimately a fair competition issue," said Roch Vaillancourt, General Counsel for HEXO.

HEXO is an award-winning consumer packaged goods company that creates and distributes prize-winning products and services for the cannabis market. The Company has been using HEXO as a trade name and mark since at least June 2018 and, with the advent of legalization in Canada, has fully adopted the name for use in connection with its products and services throughout both the adult-use (recreational) and medical cannabis markets. The Company has also established its U.S. presence with, among other things, the creation of HEXO USA Inc., and has been listed on the New York Stock Exchange since January 2019.

The settlement between HEXO and the defendants includes, among other items, the following provisions that are included in a permanent injunction approved by the Court:

"I'm pleased we were able to reach a settlement, as it is recognition that consumers associate the HEXO mark with our company and sends a message that we will not tolerate violations of our trademark rights," added Sebastien St-Louis, CEO and co-founder of HEXO. "We are creating a company and brands that can stand the test of time, and that can grow in legal markets as they become available to us."

Earlier this year, HEXO announced that it is expanding its partnership with Molson Coors to create a joint venture which will explore opportunities for non-alcohol hemp-derived CBD beverages in Colorado.

About HEXO
HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.

Forward Looking Statements
This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:
[email protected]
www.hexocorp.com

Media Relations:
(819) 317-0526
[email protected]


These press releases may also interest you

at 18:15
DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units...

at 18:07
A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the...

at 18:00
The leading cause of death worldwide is chronic inflammatory diseases. When the body is inflamed and under stress for long periods of time, the body's heart rate increases, increasing the risk of fatality. A new study published in Brain, Behavior and...

at 17:55
The global gas chromatography market  size is estimated to grow by USD 1042.59 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  7.14%  during the forecast period. ...

at 17:50
Blue Cross Blue Shield of Michigan's Board of Directors today appointed Tricia A. Keith as president and CEO-Elect. Ms. Keith, 53, will succeed Daniel J. Loepp as president and CEO following his retirement on January 1, 2025. She will become the...

at 17:45
Quest Diagnostics , a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on July 22, 2024 to shareholders of record of Quest Diagnostics common stock...



News published on and distributed by: